Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes

by Bacharier, L.B, Bateman, E.D, Boulet, L.-P, Brightling, C.E, Brusselle, G.G, Buhl, R., Cruz, A.A, Drazen, J.M, Duijts, L., FitzGerald, J.M, Fleming, L.J, Inoue, H., Ko, F.W, Krishnan, J.A, Levy, M.L, Lin, J., Mortimer, K., Pitrez, P.M, Reddel, H.K, Sheikh, A., Yorgancioglu, A.A
Published 2022

Cost-effectiveness analysis of budesonide/formoterol (Symbicort®) as needed for mild asthma in Malaysia

by Abdullah Thani, N.S.I, Neoh, C.F, Raja Gopal, V., Tan, W.
Published 2021

Treatment persistence and exacerbations in patients with asthma initiating treatment with inhaled corticosteroids and beta-adrenergic agonists: retrospective cohort study

by Fernández-Sánchez, T., Gómez Rodríguez, B., Sicras-Mainar, A., Traseira-Lugilde, S., Velasco Garrido, J.L
Published 2022

First Symbicort Generic Gains Approval

by Rubin, R.
Published 2022